diseases 2,780 words KG: ent-dise-11fceaa6 2026-03-23
kind:diseasessection:diseasesstate:published
Contents

Bulbar Palsy

Disease Info
Nucleus ambiguusInnervates the vagus (CN X) and glossopharyngeal (CN IX) nerves, controlling pharyngeal and laryngeal muscles
Hypoglossal nucleusInnervates the tongue muscles via the hypoglossal nerve (CN XII)
Solitary nucleusReceives sensory input from the vagus and glossopharyngeal nerves
Dorsal motor nucleus of the vagusProvides parasympathetic innervation to visceral organs
Pharyngeal branchImpairs swallow initiation and pharyngeal contraction
Superior laryngeal nerveDisrupts vocal cord tension and protection
Recurrent laryngeal nerveCauses vocal cord paralysis and aspiration risk
Sensory functionTaste sensation (posterior third of tongue)
Motor functionStylopharyngeus muscle (pharyngeal elevation)
Reflex controlSwallow and gag reflexes
Motor deficitsTongue weakness, atrophy, fasciculations
Functional impairmentDifficulty with chewing, swallow manipulation, and articulation
DatabasesOMIMOrphanetClinicalTrialsPubMed

Knowledge Graph

Related Analyses (3)

Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed

Related Experiments (22)

s:** - Single-cell RNA-seq to measure editing efficiency acr
falsification · proposed · Score: 0.40
Metabolic Pathway-Targeted Therapy in ALS
clinical · proposed · Score: 0.40
ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40
ALS Regional Onset and Spread: Network-Level Staging Model
clinical · proposed · Score: 0.40
Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk
clinical · proposed · Score: 0.40